New advances in artificial intelligence (AI) could streamline the process of diagnosing breast cancer. Traditional methods of mitotic counting, which assess cellular division, can be inefficient and prone to errors. With AI, this process can be standardized, reducing variability and inconsistency. However, effective implementation of these AI tools requires high-quality, diverse training data, ongoing validation, and direct feedback from pathologists. Despite the challenges, AI integration presents a promising future for breast cancer diagnostics and the broader spectrum of medical diagnostics.
CDC issues warning over recalled eggs sold in three states
The Centers for Disease Control and Prevention (CDC) has issued a warning against recalled eggs linked to 24 hospitalizations due to salmonella infection. The eggs,
